A Johns Hopkins pancreatic cancer vaccine triggered immune responses in 90% of high-risk participants, with some cysts ...
One of the biggest challenges in cancer research has been linking the "big picture" seen in medical scans with the ...
Advanced cancer diagnostics "could become faster, more quantitative, more accurate and far more broadly accessible." ...
In a survey, 93% of cancer researchers who study disparities said federal policy changes have affected them. Funding is ...
Pheast Therapeutics, a clinical-stage biotechnology company advancing next-generation macrophage-directed immunotherapies for cancer, today announced a peer-reviewed publication in Clinical Cancer ...
Long before I was a doctor, I was a caregiver. When we were in our 20s, my husband was diagnosed with an aggressive cancer. We did everything we could. We fought it with the best treatments we could ...
Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...
A powerful new AI tool has uncovered what could be one of the biggest integrity problems in modern science. After analyzing 2 ...
NRAS-, and BRAF-mutant models, including colorectal, lung, and melanoma, by resisting the RAF-mediated bypass signaling that has constrained other MEK inhibitors - ...
From uncovering metabolic drivers of metastasis to engineering light-activated anticancer drugs, biochemist Sophia Lunt paves ...
Once a reluctant Relay participant as a teen, Cody Wolf, PhD, is now an honored advocate and an American Cancer ...
To get a clearer picture of where cancer research funding is spent, we collected and compiled data covering public and charitable cancer research investments, globally, between 2016 and 2020, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results